Rheumatoid Arthritis Industry, March 2015 Market Reports from Top Publishers

You might be interested in: medical equipment, therapeutics, disease testing, biosimilar, hip replacement, total hip replacement, drug, drug delivery, microbiology, plc, injectable drug delivery, pain management therapeutics, sports medicine, stem cell.


 
1-10 of about 100 reports for Rheumatoid Arthritis

Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

Systemic Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Systemic Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Systemic Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs ...

Almirall, S.A. (Symbol:ALM) SWOT Analysis, Strategy, Revenues and Profits

Almirall, S.A. (Symbol:ALM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Insulin Resistance - Pipeline Review, H1 2015

Insulin Resistance - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Insulin Resistance - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Insulin Resistance - Pipeline Review, H1 2015', provides an overview of the Insulin Resistance's therapeutic pipeline. ...

Bone Medical Limited (Symbol:BNE) SWOT Analysis, Strategy, Revenues and Profits

Bone Medical Limited (Symbol:BNE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Can-Fite BioPharma Ltd. (Symbol:CFBI) SWOT Analysis, Strategy, Revenues and Profits

Can-Fite BioPharma Ltd. (Symbol:CFBI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

MorphoSys AG (Symbol:MOR) SWOT Analysis, Strategy, Revenues and Profits

MorphoSys AG (Symbol:MOR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Neovacs SA (Symbol:ALNEV) SWOT Analysis, Strategy, Revenues and Profits

Neovacs SA (Symbol:ALNEV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Microbio Co., Ltd. (Symbol:4128) SWOT Analysis, Strategy, Revenues and Profits

Microbio Co., Ltd. (Symbol:4128) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

About 1 400 reports for Rheumatoid Arthritis

Download Unlimited Documents from Trusted Public Sources

Astellas Annual Report 2013

  • January 2013
    142 pages
  • Drug  

  • Japan  

    World  

    Asia  

View report >

2 Companies for Rheumatoid Arthritis

Read our Company Profiles

Johnson and Johnson

United States

Amgen Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.